Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Senseonics Holdings ( (SENS) ) just unveiled an announcement.
On September 29, 2025, Senseonics Holdings, Inc. held a special meeting where stockholders approved a proposal for a reverse stock split of the company’s common stock, with a reduction in the authorized number of shares, in a range of 1-for-10 to 1-for-20. This decision, which can be enacted any time before September 29, 2026, is intended to potentially enhance the company’s stock market positioning and operational flexibility.
The most recent analyst rating on (SENS) stock is a Buy with a $1.25 price target. To see the full list of analyst forecasts on Senseonics Holdings stock, see the SENS Stock Forecast page.
Spark’s Take on SENS Stock
According to Spark, TipRanks’ AI Analyst, SENS is a Neutral.
Senseonics Holdings’ overall stock score reflects significant financial challenges, with ongoing losses and high leverage being major concerns. Despite positive developments in earnings call and corporate events, the stock’s technical indicators and valuation suggest caution.
To see Spark’s full report on SENS stock, click here.
More about Senseonics Holdings
Senseonics Holdings, Inc. operates in the medical technology industry, focusing on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes.
Average Trading Volume: 5,963,521
Technical Sentiment Signal: Strong Sell
Current Market Cap: $360.5M
Find detailed analytics on SENS stock on TipRanks’ Stock Analysis page.